Volume 34 Number 23 June 11-18, 2015
Reviews, News and Commentaries
The coming era of human phenotyping.
Nat. Biotechnol. 2015 Jun 9. 33(6) 567
Nat. Biotechnol. 2015 Jun 9. 33(6) 567
There's still a lot we don't know about the new cholesterol-lowering drugs,
by Julia Belluz, Vox, June 11
A new way to treat high cholesterol?
By Matt Sloane, Web MD, June 10
New, potent cholesterol-lowering drug gets FDA advisory approval,
by Carina Storrs, CNN, June 10
Panel tells F.D.A. to back second drug to help heart,
by Gina Kolata, New York Times, June 10
A surprising match: Cancer immunotherapy and mismatch repair,
by Francis Collins, NIH Director?s Blog, June 9
Federal panel backs approval of new drug to fight heart attacks,
by Gina Kolata, New York Times, June 9
Genetic test for 'familial' heart risk extended,
BBC, June 9
Something interesting is happening,
NIMH Director's Blog, June 9
Irreproducible biology research costs put at $28 billion per year,
by Monya Baker, Nature News, June 9
In the future, treatments tailored to patients,
by Robert Weisman, Boston Globe, June 6
Why do healthy people have harmful mutations?
By Ricki Lewis, PLOS Blogs, June 4
No hay comentarios:
Publicar un comentario